Cellectar Biosciences, Inc. (CLRB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$4.19M2011: -$7.04M2012: -$8.75M2013: -$12.40M2014: -$9.89M2015: -$8.76M2016: -$9.45M2017: -$13.60M2018: -$13.33M2019: -$14.18M2020: -$15.29M2021: -$24.13M2022: -$28.81M2023: -$38.96M2024: -$51.78M2025: -$22.98M-$22.98M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$22.98M+55.6%
2024-$51.78M-32.9%
2023-$38.96M-35.2%
2022-$28.81M-19.4%
2021-$24.13M-57.8%
2020-$15.29M-7.8%
2019-$14.18M-6.4%
2018-$13.33M+2.0%
2017-$13.60M-43.9%
2016-$9.45M-7.9%
2015-$8.76M+11.5%
2014-$9.89M+20.2%
2013-$12.40M-41.7%
2012-$8.75M-24.4%
2011-$7.04M-67.8%
2010-$4.19M